CORCEPT THERAPEUTICS INC — Director's Dealing 2016

Dec 1, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CORCEPT THERAPEUTICS INC (CORT)
CIK: 0001088856
Period of Report: 2016-11-28

Reporting Person: ENRIGHT PATRICK G (Director, 10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-11-28	Common Stock	J	2941050	$0.00	Disposed	10834849	Indirect
2016-11-28	Common Stock	J	58950	$0.00	Disposed	121153	Indirect

Footnotes

F1: Represents a pro rata distribution of shares of common stock of the Issuer held of record by Longitude Venture Partners, L.P. ("LVP") to its partners for no consideration. Longitude Capital Partners, LLC ("Longitude Capital"), the sole general partner of LVP, received a pro rata allocation of the distributed shares in accordance with its ownership.

F2: Reflects transactions and holdings of shares of common stock of the Issuer held of record by LVP. Patrick G. Enright is a managing member of Longitude Capital. Mr. Enright serves on the Board of Directors of the Issuer as the nominee of LVP. Mr. Enright disclaims beneficial ownership of the securities of the Issuer held of record by LVP, except to the extent of his pecuniary interest therein

F3: Represents a pro rata distribution of shares of common stock of the Issuer held of record by LCA to its partners for no consideration. LCP, which is the sole general partner of LCA, received a pro rata allocation of the distributed shares in accordance with its ownership.

F4: Reflects transactions and holdings of shares of common stock of the Issuer held of record by LCA. Patrick G. Enright is a managing member of Longitude Capital, the sole general partner of LCA. Mr. Enright disclaims beneficial ownership of the securities of the Issuer held of record by LCA, except to the extent of his pecuniary interest therein.